Building a Compliance Training Program
This year Q1’s Life Science Ethics & Compliance Training Conference is taking place in June in Chicago. Join us to hear from industry experts, including Daniel Simon from STERIS Corporation.
Data Integrity for Automation Engineers
Frederick Johnson of Genentech, Inc. is one of many experts presenting at Q1’s Life Sciences Manufacturing Automation Optimization Conference this April.
Mapping KOL Relationships
Q1’s 4th Annual Pharma & Biotech Medical Affairs Pre-Launch Strategies Conference taking place on April 29-30 features a mix of industry perspectives from experts, including Daniel Snyder of Revance Therapeutics, Inc.
FDA Regulatory Issues and Solutions
Jeff Gibbs from Hyman, Phelps & McNamara will be participating in the panel “Optimizing Primary Mode of Action Determination & Process to Appeal FDA Decisions” at Q1’s Combination Product Regulation Conference. See what he has to say on FDA regulatory issues below!
Bite-Sized Training Deliverables
Michael Sullivan, an expert in sales training, is presenting at Q1 Production’s 9th Annual Pharmaceutical Sales Training Conference in March.
Kathleen Crossman – FONA International Inc.
Conversation with Kathleen Crossman, Vice President of Regulatory at FONA International. She will be speaking at the Food Labeling Workshop on April 17th.
Christina DeLuca – Merck & Co., Inc.
Pharmaceutical Clinical Quality Compliance & Risk Management Conference
Bill Hagestad – Smiths Medical
2nd Annual Medical Device Cybersecurity Risk Mitigation Conference: Speaker Interview
David Festa – CooperSurgical
Semi-Annual Medical Device Supplier Quality Conference: Speaker Interview
Gary Safsten – PACCAR Inc
Semi-Annual Medical Device Supplier Quality Conference: Speaker Interview
AbbVie, Pfizer drive 2017 pharma TV ad spending above 2016’s tally
The dollars spent on TV ads for drugs is constantly growing and 2017 was no different. The number from 2016 to 2017 increased by more than $330 million. To see who contributed the most to the $3.45 billion total, click here.
Pfizer Is Ending Research Into New Drugs for Alzheimer’s and Parkinson’s Diseases
After taking a large tax cut from Trump's plan, Pfizer has decided to end research for new drugs for Alzheimer's and Parkinson's Diseases. This will also displace 300 employees. To read more about this decision, click here.
Telehealth tactics: A look at Penn Medicine’s three-tiered approach
Penn Medicine uses a unique approach to help their hospital succeed. A part of their approach is using video technology to enhance communication and collaboration. This technology can also be used for learning within OR suites as well as remote patient monitoring. See...
Teva Is Laying Off 14,000 Workers, Suspending Its Dividend
As the year comes to a close, Teva Pharmaceutical announced that they will be downsizing drastically. They will be laying off a quarter of their workforce, suspending its dividend and foregoing annual bonuses to help reduce costs. To read the full article, click here.
CONTACT US
Q1 Productions
1 W Monroe St 4th Floor
Chicago, IL 60603
T: +1 (312) 822-8100
hello@q1productions.com